Uber Technologies Inc. (UBER) and Moderna Inc. (MRNA) said Tuesday they will collaborate to explore ways to support the uptake of COVID-19 vaccines. The ridesharing and delivery company and the biotech said they will work together to provide "credible information" on vaccine safety through Uber's in-app messaging, and will look to identify opportunities to broaden access to COVID-19 vaccines. Moderna's COVID-19 vaccine was authorized in December for emergency use by the Food and Drug Administration, along with a vaccine from Pfizer Inc. (PFE) and BioNTech SE (BNTX), but the administration of the vaccines has fallen well short of expectations (link). "As part of our commitment to help address COVID-19, Moderna will be working with a coalition of partners to educate, build trust around and increase awareness of the importance of vaccination in those communities significantly impacted by the pandemic," said Moderna Chief Executive Stéphane Bancel. "We look forward to combining our expertise with Uber's capabilities and platform to support this important effort." Uber's stock rose 1.5% in premarket trading Tuesday and Moderna shares advanced 0.8%, while futures for the S&P 500 edged up 0.2%.
-Tomi Kilgore; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
01-12-21 0816ETCopyright (c) 2021 Dow Jones & Company, Inc.